Haemonetics Corp.

62
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4050241003
USD
55.12
0.75 (1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Haemonetics Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
128.00
212.00
151.00
141.00
63.00
72.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-23.00
-101.00
-74.00
25.00
-15.00
-59.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
293.00
181.00
181.00
271.00
172.00
108.00
Cash Flow from Investing Activities
-179.00
-161.00
-322.00
-143.00
-86.00
-425.00
Cash Flow from Financing Activities
-178.00
108.00
38.00
-99.00
-15.00
367.00
Net Cash Inflow / Outflow
-61.00
127.00
-105.00
24.00
67.00
54.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
0.00
-3.00
-3.00
-2.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Haemonetics Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
128.03
177.2
-49.00
-27.75%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-23.653
8.9
-31.00
-365.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
293.221
275.7
18.00
6.36%
Cash Flow from Investing Activities
-179.547
-51.1
-128.00
-251.36%
Cash Flow from Financing Activities
-178.46
-170.9
-8.00
-4.42%
Net Cash Inflow / Outflow
-61.323
142.6
-203.00
-143.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.463
88.9
-85.00
-96.10%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 61.35% vs -0.01% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
293.22
181.72
61.35%